Mechanism
Myelin basic protein-mimetic immunomodulation
Assets acting on this target.
- Class
- Glatiramer acetate (random co-polymer)
This mechanism describes glatiramer acetate, a synthetic random co-polymer built from four amino acids (glutamic acid, lysine, alanine, and tyrosine) assembled in proportions that mimic myelin basic protein, a structural protein found in the myelin sheath that insulates nerve fibers. In multiple sclerosis, the immune system mistakenly recognizes myelin components as foreign and mounts a T-cell-driven attack that damages this insulation, disrupting nerve signal conduction. Because the co-polymer structurally resembles myelin basic protein, it can engage the same antigen-presentation and T-cell recognition machinery, effectively acting as a decoy that redirects and dampens the pathogenic immune response rather than suppressing immunity broadly. This approach reflects a rationale distinct from generalized immunosuppression: rather than blunting immune function across the board, an antigen-mimetic aims to selectively recalibrate the specific autoimmune response responsible for tissue damage. This class of mechanism matters wherever autoimmune attack against a defined self-antigen drives disease, with multiple sclerosis being the principal established context, since disease activity there is closely tied to immune cells reacting against myelin components in the brain and spinal cord.
Explore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
1 of 1 assets